Skip to main content
. 2022 May 20;13:867500. doi: 10.3389/fphar.2022.867500

FIGURE 1.

FIGURE 1

Schematic representation of the proposed mechanism underlying melatonin’s protective effects on diabetes caused by inflammatory inducers including Lipopolysaccharides (LPS) and Reactive Oxygen Species (ROS).